相关文章
RELATED ARTICLES详细介绍
依匹哌唑杂质对照品 提供结构确证
随货提供:所有杂质对照品均随货提供HPLC,NMR,MS图谱及CoA证书。
杂质定制服务:我司有专业研发团队,可提供杂质定制服务,以大可能的满足您对杂质对照品的选购需求。
依匹哌唑杂质对照品 提供结构确证
中文名称 | 英文名称 | CAS号 |
依匹哌唑标准品 | Brexpiprazole | 913611-97-9 |
依匹哌唑杂质1 | 1,4-bis(benzo[b]thiophen-4-yl)piperazine | 1420987-86-5 |
依匹哌唑杂质2 | 7-hydroxyquinolin-2(1H)-one | 70500-72-0 |
依匹哌唑杂质3 | 7-hydroxy-3,4-dihydroquinolin-2(1H)-one | 22246-18-0 |
依匹哌唑杂质4 | 7-(4-hydroxybutoxy)quinolin-2(1H)-one | 1008531-47-2 |
依匹哌唑杂质5 | 7-(4-chlorobutoxy)quinolin-2(1H)-one | 913613-82-8 |
依匹哌唑杂质6 | 7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) |
|
依匹哌唑杂质7 | Brexpiprazole N-Oxide | 1191900-58-9 |
依匹哌唑杂质8 | 1-(benzo[b]thiophen-4-yl)-4-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazine 1,4-dioxide |
|
依匹哌唑杂质9 | 5-hydroxyquinolin-2(1H)-one | 31570-97-5 |
依匹哌唑杂质10 | 5-(4-chlorobutoxy)quinolin-2(1H)-one |
|
依匹哌唑杂质11 | 5-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one |
|
依匹哌唑杂质12 | 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one |
|
依匹哌唑杂质13 | 1,4-bis(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butane |
|
依匹哌唑杂质14 | 5-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1,8a-dihydroquinolin-2(4aH)-one |
|
依匹哌唑杂质15 | Brexpiprazole S-Oxide | 1191900-51-2 |
依匹哌唑杂质16 | 7-(4-bromobutoxy)-1-(4-bromobutyl)quinolin-2(1H)-one |
|
依匹哌唑杂质17 | 7-(4-chlorobutoxy)-1-(4-chlorobutyl)quinolin-2(1H)-one |
|
依匹哌唑杂质18 | 6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one |
|
依匹哌唑杂质19 | 6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)-one |
|
依匹哌唑杂质20 | 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-chlorobutyl)quinolin-2(1H)-one |
|
依匹哌唑杂质21 | 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-bromobutyl)quinolin-2(1H)-one |
|
依匹哌唑杂质22 | 2,7-bis(4-chlorobutoxy)quinoline |
|
依匹哌唑杂质23 | 7-(pent-4-enyloxy)quinolin-2(1H)-one |
|
依匹哌唑杂质24 | 7-(4-(4-(benzo[b]thiophen-5-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one |
|
依匹哌唑杂质25 | 7-(4-(4-(benzo[b]thiophen-7-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one |
|
依匹哌唑杂质26 | 7,7'-((oxybis(butane-4,1-diyl))bis(oxy))bis(quinolin-2(1H)-one) |
|
依匹哌唑杂质27 | 7-(4-(4-([2,4'-bibenzo[b]thiophen]-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one |
精神分裂症的治疗已经成为了世界性难题,世界卫生组织预计每年大约有 100 万人因精神分裂症而失去生命,据美国国家心理卫生研究所提供的信息,在美国大约有240万精神分裂症成人患者,大约75%的患者在某些情况下会经历病情的复发及恶化。由于精神分裂症可能不是由一个单一蛋白功能失调造成,因此现在以单个靶点为中心的主流研发模式很难达到满意的效果,此类新药研发进展十分缓慢,安慰剂效应很大。
产品咨询
销售热线
微信公众号
移动端浏览